geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Rofecoxib


, : Rofecoxib. Expert Opinion on PharmacoTherapy 1(5): 1053-1066

Rofecoxib (Vioxx, Merck & Co., Inc.) is a new orally-effective non-steroidal anti-inflammatory drug (NSAID) approved for treatment of acute pain, fever, primary dysmenorrhea and pain and inflammation in osteoarthritis (OA). It is also being evaluated for treatment of rheumatoid arthritis and adenomatous polyps of the colon. Rofecoxib is a specific inhibitor of cyclooxygenase-2 (COX-2), thereby inhibiting prostanoid synthesis in cells that express COX-2, including inflammatory cells. As cells in the gastrointestinal (GI) tract principally express COX-1, a different isoform of cyclooxygenase, it is predicted that rofecoxib will have less GI toxicity than other less selective NSAIDs. In clinical trials, rofecoxib was found to be as effective as other NSAIDs for management of pain and inflammation. In trials that compare rofecoxib with ibuprofen, diclofenac and indomethacin, less GI toxicity has been observed, as assayed by a decrease in lesions visible on endoscopy, by GI blood loss and, in a meta-analysis, by frequency of serious adverse GI events. The presence of COX-2 in cells other than inflammatory cells results in side effects common among NSAIDs, including peripheral oedema and hypertension. These side effects are dose-dependent. Rofecoxib, together with other branded NSAIDs, are relatively expensive, which has led to concern regarding costs versus benefits. There is also concern regarding potential risks associated with the use of rofecoxib by populations that would otherwise not tolerate NSAIDs.

US$19.90

PMID: 11249495

DOI: 10.1517/14656566.1.5.1053


Other references

Nedelciuc, C.; Florea, A.; Draghici, I., 1976: Effect of chemical fertilizer on the yield and nutritive quality of irrigated Italian ryegrass (Lolium multiflorum). In field trials in 1971-2, Italian ryegrass was given various combinations of 0-600 kg N, 0-120 kg P2O5 and 120 kg K2O/ha. Av. total yields for 2 yr increased from 6.7 t DM/ha without applied N to 17.73 t with 600 kg N/ha and from 13.37 t/ha witho...

Wells, R.; Ashley, D.A.; Boerma, H.R.; Reger, B.J., 1986: Physiological comparisons of two soybean glycine max cultivars differing in canopy photosynthesis ii. variation in specific leaf weight nitrogen and protein components. Cultivar differences in canopy apparent photosynthesis (CAP) have been observed in soybean (Glycine max (L.) Merr.) but little is known about the physiological mechanisms which are responsible for such differences. This study was initiated to dete...

Hoskins, Johnny D., 1999: Are you looking for protein-losing enteropathies?. DVM 30(4

O.K.C., 1972: Some observations on the binding of iodo vancomycin to the cell membrane of growth inhibited micrococcus lysodeikticus cells. Malaysian Journal of Science 1: 45-52

Lodhi, G.P.; Paroda, R.S.; Ram, H., 1978: Gene effects in interspecific crosses of eu sorghum. The gene effects for 9 quantitative characters were studied in 7 interspecific crosses of Sorghum in 1974. Additive, dominance and additive .times. additive gene effects played a major role in the inheritance of these characters. The additive comp...

Carey, N.; Courtenay, M.; Stenner, K., 2014: The prescribing practices of nurses who care for patients with skin conditions: a questionnaire survey. To explore the practice of nurses who prescribe medication for patients with skin conditions. Nurses have lead roles in dermatology services. In the United Kingdom, nurses in primary care frequently prescribe medicines for skin conditions, but the...

Metello, J.; Nogueira, B.; Torgal, M.; Colaço, J.; Vieira, A.; Gonçalves, V.; Retto, H., 2007: Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride. Overactive bladder syndrome (OBS) is described as urinary urgency with or without incontinence, usually with increased daytime frequency and nocturia in the absence of another identifiable pathological process. Nowadays and despite other alternati...

Boukal, Milan., 1997: The localities of Cercyon Paracycreon laminatus and Cryptopleurum subtile hitherto known in the Czech and Slovak Republic with remarks on their ecology Coleoptera Hydrophilidae Sphaeridiinae Dosud zname lokality Cercyon Paracycreon laminatus a Cryptopleurum subtile v Ceske a Slovenske republice a poznamky k ekologii techto druhu Coleoptera Hydrophilidae Sphaeridiinae. Klapalekiana. Dec 20; 333-4: 143-149

Dodin, A.; Zylberberg, B.; Delorme, L., 1992: In vivo and in vitro antitumoral effects of an extract from Vibrio cholerae within different murine models: I. In vivo effect of a bacterial extract from Vibrio cholerae on the evolution of different murine tumoral grafts. A bacterial extract from Vibrio cholerae, so called DGZ, is shown to prevent transplantation of sarcoma 180 and Lewis lung carcinoma. A 4 days DGZ treatment (4 times 100 mu-g) triggers reject of the graft by 40% of the mice. The mice which have re...

Stoor, P.; Kirstila, V.; Soderling, E.; Kangasniemi, I.; Herbst, K.; Yli Urpo, A., 1996: Interactions between bioactive glass and periodontal pathogens. Bioactive glasses have been used in periodontal applications such as grafting infrabony periodontal lesions. We studied a bioactive glass S53P4 for its possible antibacterial effects on the periodontal pathogens Porphyromonas gingivalis, Prevotell...